Genetic alterations of the p53 gene are a feature of malignant mesotheliomas.

Abstract:

:A putative tumor suppressor gene, p53, has been shown to be altered in a variety of human tumor types. The primary mechanism of p53 inactivation is believed to be mutation of one allele followed by loss of the second allele. Malignant mesothelioma is a tumor that has been highly associated with exposure to asbestos fibers, which are known to cause chromosomal abnormalities in mesothelial cells. We have examined four mesothelioma cell lines for genetic abnormalities in p53. Cytogenetic analysis revealed that two of the four tumors had abnormalities (numerical and/or structural) of chromosome 17 (the locus of the p53 gene). Restriction fragment length polymorphism analysis using a chromosome 17p-specific probe (pYNZ22) revealed that two tumors had loss of heterozygosity in the region of 17p13. The relative level of p53 mRNA expression was examined by Northern analysis, with one tumor showing negligible expression of p53 mRNA. The complementary DNA of p53 was generated from the three tumors showing detectable mRNA expression, and the region between codons 70 and 319 was amplified by the polymerase chain reaction and sequenced. DNA single-base substitutions were detected in two of the tumor cell lines, each resulting in amino acid substitutions. One tumor had an arginine to histidine substitution at position 175, and one tumor had a glycine to aspartic acid substitution at position 245. The observed mutations took place in regions of high cross-species sequence homology, indicating that these regions may be functionally important. The correlation of chromosomal loss in 17p on the cytogenetic and molecular level along with p53 mRNA expression and DNA sequence data indicate that genetic alterations in p53 could be a feature of malignant mesotheliomas and may reveal an important role of asbestos fibers in tumor suppressor gene inactivation.

journal_name

Cancer Res

journal_title

Cancer research

authors

Cote RJ,Jhanwar SC,Novick S,Pellicer A

subject

Has Abstract

pub_date

1991-10-01 00:00:00

pages

5410-6

issue

19

eissn

0008-5472

issn

1538-7445

journal_volume

51

pub_type

杂志文章
  • Mutational analysis of the H-ras oncogene in spontaneous C57BL/6 x C3H/He mouse liver tumors and tumors induced with genotoxic and nongenotoxic hepatocarcinogens.

    abstract::The frequency and mutational profile of H-ras gene activation were determined in spontaneous liver tumors of male C57BL/6 x C3H/He mice and in tumors induced with the genotoxic hepatocarcinogen benzidine.2 HCl or the nongenotoxic hepatocarcinogens phenobarbital, chloroform, and ciprofibrate. DNA sequence analysis of t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Fox TR,Schumann AM,Watanabe PG,Yano BL,Maher VM,McCormick JJ

    更新日期:1990-07-01 00:00:00

  • Centrosome amplification and overexpression of aurora A are early events in rat mammary carcinogenesis.

    abstract::The cells of many solid tumors have been found to contain supernumerary centrosomes, a condition known as centrosome amplification. Centrosome amplification, accompanied by the overexpression of an associated kinase, Aurora A (AurA), has been implicated in mechanisms leading to mitotic spindle aberrations, aneuploidy,...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goepfert TM,Adigun YE,Zhong L,Gay J,Medina D,Brinkley WR

    更新日期:2002-07-15 00:00:00

  • Stromelysin-1 promoter mutations impair gelatinase B activation in high microsatellite instability sporadic colorectal tumors.

    abstract::Colorectal cancers from the mutator phenotype pathway display distinctive pathological features and confer a lesser aggressiveness than colorectal adenocarcinomas originated by the suppressor pathway. The goal of this work was to test whether tumors developed through the mutator pathway could show a decrease in matrix...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Morán A,Iniesta P,de Juan C,González-Quevedo R,Sánchez-Pernaute A,Díaz-Rubio E,Ramón y Cajal S,Torres A,Balibrea JL,Benito M

    更新日期:2002-07-01 00:00:00

  • Protein transduction of dendritic cells for NY-ESO-1-based immunotherapy of myeloma.

    abstract::Myeloma vaccines, based on dendritic cells pulsed with idiotype or tumor lysate, have been met with limited success, probably in part due to insufficient cross-priming of myeloma antigens. A powerful method to introduce myeloma-associated antigens into the cytosol of dendritic cells is protein transduction, a process ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1383

    authors: Batchu RB,Moreno AM,Szmania SM,Bennett G,Spagnoli GC,Ponnazhagan S,Barlogie B,Tricot G,van Rhee F

    更新日期:2005-11-01 00:00:00

  • The bioreductive prodrug PR-104A is activated under aerobic conditions by human aldo-keto reductase 1C3.

    abstract::PR-104, currently in phase II clinical trials, is a phosphate ester pre-prodrug which is converted in vivo to its cognate alcohol, PR-104A, a prodrug designed to exploit tumor hypoxia. Bioactivation occurs via one-electron reduction to DNA crosslinking metabolites in the absence of oxygen. However, certain tumor cell ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-3237

    authors: Guise CP,Abbattista MR,Singleton RS,Holford SD,Connolly J,Dachs GU,Fox SB,Pollock R,Harvey J,Guilford P,Doñate F,Wilson WR,Patterson AV

    更新日期:2010-02-15 00:00:00

  • Frequent mutation of Apc gene in rat colon tumors and mucin-depleted foci, preneoplastic lesions in experimental colon carcinogenesis.

    abstract::Mucin-depleted foci (MDF) are microscopic dysplastic lesions induced in the colon of rodents by specific colon carcinogens. Most MDF show Wnt pathway activation, whereas only a subset shows mutations in the Ctnnb1 gene, coding for beta-catenin. Because Apc is a member of the Wnt pathway and the most frequent mutated g...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3861

    authors: Femia AP,Dolara P,Giannini A,Salvadori M,Biggeri A,Caderni G

    更新日期:2007-01-15 00:00:00

  • Identification of fractalkine, a CX3C-type chemokine, as a direct target of p53.

    abstract::Fractalkine is a CX3C-type chemokine that induces chemotaxis of monocytes and cytotoxic T cells. Using the differential display method for examining gene expression in p53-defective cells transfected by adenovirus containing wild-type p53, we observed that fractalkine was induced by ectopic expression of p53. An elect...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shiraishi K,Fukuda S,Mori T,Matsuda K,Yamaguchi T,Tanikawa C,Ogawa M,Nakamura Y,Arakawa H

    更新日期:2000-07-15 00:00:00

  • Expression of differentiation melanoma-associated antigen genes is associated with favorable disease outcome in advanced-stage melanomas.

    abstract::Cutaneous melanomas have been found to express several immunogenic differentiation melanoma-associated antigens (MAAs) that have been suggested to play an important role in disease outcome. Adaptive host immunity to MAAs has shown some level of control on melanoma progression. To date, there has been no definitive rep...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Takeuchi H,Kuo C,Morton DL,Wang HJ,Hoon DS

    更新日期:2003-01-15 00:00:00

  • ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.

    abstract::Overexpression of the prosurvival Bcl-2 family members (Bcl-2, Bcl-xL, and Mcl-1) is commonly associated with tumor maintenance, progression, and chemoresistance. We previously reported the discovery of ABT-737, a potent, small-molecule Bcl-2 family protein inhibitor. A major limitation of ABT-737 is that it is not or...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-07-5836

    authors: Tse C,Shoemaker AR,Adickes J,Anderson MG,Chen J,Jin S,Johnson EF,Marsh KC,Mitten MJ,Nimmer P,Roberts L,Tahir SK,Xiao Y,Yang X,Zhang H,Fesik S,Rosenberg SH,Elmore SW

    更新日期:2008-05-01 00:00:00

  • alpha-Fetoprotein as a carrier protein in plasma and its bilirubin-binding ability.

    abstract::The bilirubin-binding ability of human alpha-fetoproteins, which were purified from fetal cord serum and from ascites fluid of a hepatoma-bearing patient, was examined by the difference spectrum and the Jacobsen peroxidase methods. The difference spectrum observed as a result of the specific binding of bilirubin to al...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Aoyagi Y,Ikenaka T,Ichida F

    更新日期:1979-09-01 00:00:00

  • Effects of in vivo Friend leukemia virus infection on levels of serum thymic factors and on selected T-cell functions in mice.

    abstract::The levels of serum thymic factor(s) (STF), of Thy-1.2 positivity of splenocytes [as measured by their azathioprine (AZ) sensitivity], and of Thy-1.2-positive "spontaneous" spleen rosette-forming cells (SSRFCs), as well as the presence of infectious virus in the thymus, were assessed as a function of time after virus ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Tonietti G,Rossi GB,Del Gobbo V,Accinni L,Ranucci A,Titti F,Premrov MG,Garaci E

    更新日期:1983-09-01 00:00:00

  • Expression of metallothionein II in intestinal metaplasia, dysplasia, and gastric cancer.

    abstract::Differential display is a valuable tool for the identification of differentially expressed genes in human carcinogenesis and development. The search for differentially expressed genes in gastric cancer and its premalignant lesions may help to define molecular alterations in the gastric mucosa that may precede the deve...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ebert MP,Günther T,Hoffmann J,Yu J,Miehlke S,Schulz HU,Roessner A,Korc M,Malfertheiner P

    更新日期:2000-04-01 00:00:00

  • Breast Cancer Resistance to Antiestrogens Is Enhanced by Increased ER Degradation and ERBB2 Expression.

    abstract::Endocrine therapies effectively improve the outcomes of patients with estrogen receptor (ER)-positive breast cancer. However, the emergence of drug-resistant tumors creates a core clinical challenge. In breast cancer cells rendered resistant to the antiestrogen fulvestrant, we defined causative mechanistic roles for t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1593

    authors: Shibata T,Watari K,Izumi H,Kawahara A,Hattori S,Fukumitsu C,Murakami Y,Takahashi R,Toh U,Ito KI,Ohdo S,Tanaka M,Kage M,Kuwano M,Ono M

    更新日期:2017-01-15 00:00:00

  • DNA fingerprinting of 7,12-dimethylbenz[a]anthracene-induced and spontaneous CD-1 mouse liver tumors.

    abstract::Determining to what degree chemicals and environmental agents contribute to the development of cancer would be materially enhanced by the ability to distinguish chemically induced tumors from those that arise spontaneously. Using DNA fingerprinting as an assay, we investigated whether somatic DNA rearrangements are mo...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ledwith BJ,Storer RD,Prahalada S,Manam S,Leander KR,van Zwieten MJ,Nichols WW,Bradley MO

    更新日期:1990-09-01 00:00:00

  • Nicotinamide blocks proliferation and induces apoptosis of chronic lymphocytic leukemia cells through activation of the p53/miR-34a/SIRT1 tumor suppressor network.

    abstract::Because of its relatively indolent clinical course, chronic lymphocytic leukemia (CLL) offers a versatile model for testing novel therapeutic regimens and drug combinations. Nicotinamide is the main NAD(+) precursor and a direct inhibitor of four classes of enzymes, including the sirtuins. SIRT1, the main member of th...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-4452

    authors: Audrito V,Vaisitti T,Rossi D,Gottardi D,D'Arena G,Laurenti L,Gaidano G,Malavasi F,Deaglio S

    更新日期:2011-07-01 00:00:00

  • Characterizing extravascular fluid transport of macromolecules in the tumor interstitium by magnetic resonance imaging.

    abstract::Noninvasive imaging techniques to image and characterize delivery and transport of macromolecules through the extracellular matrix (ECM) and supporting stroma of a tumor are necessary to develop treatments that alter the porosity and integrity of the ECM for improved delivery of therapeutic agents and to understand fa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-04-3682

    authors: Pathak AP,Artemov D,Ward BD,Jackson DG,Neeman M,Bhujwalla ZM

    更新日期:2005-02-15 00:00:00

  • Eighteenth annual pezcoller symposium: tumor microenvironment and heterotypic interactions.

    abstract::This symposium was held in Trento, Italy, from June 27 to 29, 2006, and was co-chaired by Robert Weinberg and Enrico Mihich. The interactions between tumor cells and their microenvironment were discussed with particular emphasis on their molecular mechanisms. The roles of transforming growth factor beta signaling, uro...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-06-3149

    authors: Weinberg R,Mihich E

    更新日期:2006-12-15 00:00:00

  • BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner.

    abstract::Mouse polyclonal antibodies, raised against three regions of the human BRCA1 protein, were characterized and revealed BRCA1 as a 220-kDa nuclear phosphoprotein in normal cells. All three antisera recognize both in vitro-translated and recombinant, baculovirus-derived BRCA1, which co-migrate with BRCA1 from the human b...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Chen Y,Farmer AA,Chen CF,Jones DC,Chen PL,Lee WH

    更新日期:1996-07-15 00:00:00

  • Immunization against feline oncarnavirus disease using a killed tumor cell vaccine.

    abstract::Specific pathogen-free cats were immunized with an inactivated feline oncornavirus tumor cell vaccine. Immunized cats produced high antibody titers to the feline oncornavirus-associated cell membrane antigen and were protected from oncogenic feline sarcoma virus challenge. However, immunization did not produce virus-n...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Olsen RG,Hoover EA,Mathes LE,Heding L,Schaller JP

    更新日期:1976-10-01 00:00:00

  • Phase I assessment of new mechanism-based pharmacodynamic biomarkers for MLN8054, a small-molecule inhibitor of Aurora A kinase.

    abstract::The mitotic kinase Aurora A is an important therapeutic target for cancer therapy. This study evaluated new mechanism-based pharmacodynamic biomarkers in cancer patients in two phase I studies of MLN8054, a small-molecule inhibitor of Aurora A kinase. Patients with advanced solid tumors received MLN8054 orally for 7 c...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-1030

    authors: Chakravarty A,Shinde V,Tabernero J,Cervantes A,Cohen RB,Dees EC,Burris H,Infante JR,Macarulla T,Elez E,Andreu J,Rodriguez-Braun E,Rosello S,von Mehren M,Meropol NJ,Langer CJ,ONeil B,Bowman D,Zhang M,Danaee H,Faron

    更新日期:2011-02-01 00:00:00

  • Immunological block to synthetic alpha-melanocyte-stimulating hormone: melanocyte interaction by antibodies isolated from cell-column immunoadsorbents.

    abstract::Antibodies to formalin-fixed, syngeneic melanoma cells were prepared in mice, purified by immunoaffinity chromatography, and tested for binding activity to viable melanoma cells. The radiolabeled antibodies detected congruent to 9 X 10(6) melanoma antigenic sites/cell. The calculated average association constant (Ka) ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Winkelhake JL,Elcombe BM,Hodach A

    更新日期:1979-08-01 00:00:00

  • CUB domain-containing protein 1, a prognostic factor for human pancreatic cancers, promotes cell migration and extracellular matrix degradation.

    abstract::CUB domain-containing protein 1 (CDCP1) is a membrane protein that is highly expressed in several solid cancers. We reported previously that CDCP1 regulates anoikis resistance as well as cancer cell migration and invasion, although the underlying mechanisms have not been elucidated. In this study, we found that expres...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-0220

    authors: Miyazawa Y,Uekita T,Hiraoka N,Fujii S,Kosuge T,Kanai Y,Nojima Y,Sakai R

    更新日期:2010-06-15 00:00:00

  • Discovery and pharmacologic characterization of CP-724,714, a selective ErbB2 tyrosine kinase inhibitor.

    abstract::Amplification and overexpression of erbB2 (Her-2/neu) proto-oncogene has been linked to human malignancies including tumors of the breast, ovary, and stomach. It has been implicated in tumor growth, sensitivity to standard chemotherapy, prognosis of patients, and disease-free survival. Although the clinical use of tra...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-3559

    authors: Jani JP,Finn RS,Campbell M,Coleman KG,Connell RD,Currier N,Emerson EO,Floyd E,Harriman S,Kath JC,Morris J,Moyer JD,Pustilnik LR,Rafidi K,Ralston S,Rossi AM,Steyn SJ,Wagner L,Winter SM,Bhattacharya SK

    更新日期:2007-10-15 00:00:00

  • TMPRSS2 fusions with oncogenic ETS factors in prostate cancer involve unbalanced genomic rearrangements and are associated with HDAC1 and epigenetic reprogramming.

    abstract::Translocations fusing the strong androgen-responsive gene, TMPRSS2, with ERG or other oncogenic ETS factors may facilitate prostate cancer development. Here, we studied 18 advanced prostate cancers for ETS factor alterations, using reverse transcription-PCR and DNA and RNA array technologies, and identified putative E...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-06-1986

    authors: Iljin K,Wolf M,Edgren H,Gupta S,Kilpinen S,Skotheim RI,Peltola M,Smit F,Verhaegh G,Schalken J,Nees M,Kallioniemi O

    更新日期:2006-11-01 00:00:00

  • eEF-2 kinase dictates cross-talk between autophagy and apoptosis induced by Akt Inhibition, thereby modulating cytotoxicity of novel Akt inhibitor MK-2206.

    abstract::Inhibition of the survival kinase Akt can trigger apoptosis, and also has been found to activate autophagy, which may confound tumor attack. In this study, we investigated regulatory mechanisms through which apoptosis and autophagy were modulated in tumor cells subjected to Akt inhibition by MK-2206, the first alloste...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-10-2889

    authors: Cheng Y,Ren X,Zhang Y,Patel R,Sharma A,Wu H,Robertson GP,Yan L,Rubin E,Yang JM

    更新日期:2011-04-01 00:00:00

  • Proteolysis of CCN1 by plasmin: functional implications.

    abstract::Plasmin is shown to play a crucial role in many pathophysiologic processes primarily through its ability to degrade extracellular matrix (ECM) and/or mobilizing growth factors that are sequestered in the ECM. Cysteine-rich 61 (CCN1) is a matricellular protein of which expression is up-regulated in cancer and various v...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-0982

    authors: Pendurthi UR,Tran TT,Post M,Rao LV

    更新日期:2005-11-01 00:00:00

  • ATM acts downstream of ATR in the DNA damage response signaling of bystander cells.

    abstract::This study identifies ataxia-telangiectasia mutated (ATM) as a further component of the complex signaling network of radiation-induced DNA damage in nontargeted bystander cells downstream of ataxia-telangiectasia and Rad3-related (ATR) and provides a rationale for molecular targeted modulation of these effects. In dir...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-08-0545

    authors: Burdak-Rothkamm S,Rothkamm K,Prise KM

    更新日期:2008-09-01 00:00:00

  • In vitro and in vivo cytotoxicity of rhodamine 123 combined with hyperthermia.

    abstract::Because both Rhodamine 123 (R123) and hyperthermia have been shown to be cytotoxic, we examined their effect, independently and in combination, on five different human malignant cell lines in vitro and on cultured melanoma cells grown intradermally in nude mice. The cell lines examined include two human melanomas, UCL...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Goffney WH,Wong JH,Kern DH,Chase D,Krag DN,Storm FK

    更新日期:1990-02-01 00:00:00

  • PDT: What's Past Is Prologue.

    abstract::Despite descriptions of light-mediated therapy in ancient texts and the discovery of photodynamic therapy (PDT) in the early 1900s, the landmark article in 1978 in Cancer Research by Dougherty and his colleagues at the Roswell Park Cancer Institute remains rightly viewed as the starting point for clinical PDT in moder...

    journal_title:Cancer research

    pub_type: 社论,历史文章

    doi:10.1158/0008-5472.CAN-16-0927

    authors: Cengel KA,Simone CB 2nd,Glatstein E

    更新日期:2016-05-01 00:00:00

  • Inhibition of 7,12-dimethylbenz(a)anthracene-induced mammary tumors and DNA adducts by dietary selenite.

    abstract::The present studies were designed to examine the influence of dietary selenite supplementation on the initiation phase of 7,12-dimethylbenz(a)anthracene (DMBA)-induced mammary carcinogenesis and to correlate selenite-induced changes in the binding of DMBA metabolites to rat mammary cell DNA with the ultimate tumor inc...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Liu JZ,Gilbert K,Parker HM,Haschek WM,Milner JA

    更新日期:1991-09-01 00:00:00